China National Accord Medicines Corp Ltd (200028) - Cash Flow Conversion Efficiency
Based on the latest financial reports, China National Accord Medicines Corp Ltd (200028) has a cash flow conversion efficiency ratio of -0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (HK$-424.00 Million) by net assets (HK$21.55 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
China National Accord Medicines Corp Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how China National Accord Medicines Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
China National Accord Medicines Corp Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of China National Accord Medicines Corp Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
New Best Wire Industrial Co Ltd
TWO:5013
|
-0.001x |
|
Almogim Holdings Ltd
TA:ALMA
|
-0.180x |
|
Wattanapat Hospital Trang Public Company Limited
BK:WPH
|
0.047x |
|
I Controls Inc
KO:039570
|
0.143x |
|
EDAP TMS SA
NASDAQ:EDAP
|
-0.123x |
|
Monte Carlo Fashions Limited
NSE:MONTECARLO
|
-0.221x |
|
Birikim Varlik Yonetim A.S.
IS:BRKVY
|
-0.079x |
|
Penta Teknoloji Urunleri Dagitim Ticaret AS
IS:PENTA
|
0.008x |
Annual Cash Flow Conversion Efficiency for China National Accord Medicines Corp Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of China National Accord Medicines Corp Ltd from 1998 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | HK$20.76 Billion | HK$3.27 Billion | 0.158x | +12.58% |
| 2023-12-31 | HK$20.98 Billion | HK$2.94 Billion | 0.140x | +6.33% |
| 2022-12-31 | HK$19.44 Billion | HK$2.56 Billion | 0.132x | +43.38% |
| 2021-12-31 | HK$18.02 Billion | HK$1.66 Billion | 0.092x | +3.22% |
| 2020-12-31 | HK$16.89 Billion | HK$1.50 Billion | 0.089x | -31.68% |
| 2019-12-31 | HK$15.36 Billion | HK$2.00 Billion | 0.130x | +36.93% |
| 2018-12-31 | HK$13.91 Billion | HK$1.32 Billion | 0.095x | -26.54% |
| 2017-12-31 | HK$9.93 Billion | HK$1.29 Billion | 0.129x | -21.63% |
| 2016-12-31 | HK$8.91 Billion | HK$1.47 Billion | 0.165x | -12.25% |
| 2015-12-31 | HK$5.57 Billion | HK$1.05 Billion | 0.188x | +214.64% |
| 2014-12-31 | HK$4.85 Billion | HK$-796.70 Million | -0.164x | -181.81% |
| 2013-12-31 | HK$2.32 Billion | HK$465.03 Million | 0.201x | +13.95% |
| 2012-12-31 | HK$1.84 Billion | HK$323.96 Million | 0.176x | +10.57% |
| 2011-12-31 | HK$1.43 Billion | HK$227.32 Million | 0.159x | -57.90% |
| 2010-12-31 | HK$1.13 Billion | HK$428.16 Million | 0.378x | +22.69% |
| 2009-12-31 | HK$878.13 Million | HK$270.85 Million | 0.308x | -18.77% |
| 2008-12-31 | HK$649.37 Million | HK$246.58 Million | 0.380x | +124.10% |
| 2007-12-31 | HK$517.58 Million | HK$87.70 Million | 0.169x | -55.91% |
| 2006-12-31 | HK$472.90 Million | HK$181.73 Million | 0.384x | +2.04% |
| 2005-12-31 | HK$393.72 Million | HK$148.28 Million | 0.377x | +3.53% |
| 2004-12-31 | HK$358.20 Million | HK$130.30 Million | 0.364x | +53.55% |
| 2003-12-31 | HK$342.86 Million | HK$81.22 Million | 0.237x | +175.64% |
| 2002-12-31 | HK$334.70 Million | HK$28.76 Million | 0.086x | -55.98% |
| 2001-12-31 | HK$364.45 Million | HK$71.16 Million | 0.195x | +828.36% |
| 2000-12-31 | HK$405.06 Million | HK$8.52 Million | 0.021x | -58.36% |
| 1999-12-31 | HK$452.23 Million | HK$22.84 Million | 0.051x | +334.65% |
| 1998-12-31 | HK$448.25 Million | HK$5.21 Million | 0.012x | -- |
About China National Accord Medicines Corp Ltd
China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers new and special drugs and medications for chronic diseases. It also provides traditional Chinese medicine, Western medicine, rehabilitation therapy, and various medical-related resources, as well as chemical drugs, OTC drugs, and healt… Read more